Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gravina

Showing results (1011-1020 of 1,077) with videos related to

Pageof 108
Sort By:
Biomedical Reports|January 14, 2020
Palliative radiotherapy in advanced cancer patients treated with immune-checkpoint inhibitors: The PRACTICE studyMelissa Bersanelli, Elisabetta Lattanzi, Nunziata D'Abbiero, et al.
The Canadian Journal of Cardiology|February 4, 2018
Long-Term Outcomes of Percutaneous Coronary Intervention for Chronic Total Occlusion in Patients Who Have Undergone Coronary Artery Bypass Grafting vs Those Who Have NotLorenzo Azzalini, Soledad Ojeda, Aris Karatasakis, et al.
Cell Death & Disease|October 30, 2015
A novel miR-371a-5p-mediated pathway, leading to BAG3 upregulation in cardiomyocytes in response to epinephrine, is lost in Takotsubo cardiomyopathyM d'Avenia, R Citro, M De Marco, et al.
Biochemistry|January 27, 2026
Sweet Protein Allosteric Binding and Activation of the Human T1R2/R3 Sweet Receptor: A Simulation Model Validated by in Vitro Receptor Activation AssayPhillip Vo, Daniel E Connors, Brendan P Sharkey, et al.
JAMA Network Open|November 2, 2023
Antitumor Activity and Safety of Dostarlimab Monotherapy in Patients With Mismatch Repair Deficient Solid Tumors: A Nonrandomized Controlled TrialThierry André, Dominique Berton, Giuseppe Curigliano, et al.
Cell Death & Disease|June 1, 2026
Multi-omics analyses identify EZH2 as a central driver in rhabdomyosarcoma radioresistance and highlight Tazemetostat as an effective radiosensitizer in vitro and in vivoMatteo Cassandri, Antonella Porrazzo, Simona Camero, et al.
United European Gastroenterology Journal|December 24, 2022
Effectiveness of first and second-line empirical treatment in Italy: Results of the European registry on Helicobacter pylori managementLuigi Gatta, Olga P Nyssen, Giulia Fiorini, et al.
Anticancer Research|July 7, 2021
Resilience in Radiotherapy Services During the COVID-19 Emergency: Collaboration Between the Regional Radiation Oncology Departments of Lazio, Abruzzo and MoliseMartina DE Angeli, Dimitri Anzellini, Giancarlo Arcangeli, et al.
International Journal of Radiation Biology|March 4, 2025
Significant interruptions in radiotherapy during curative treatment for prostate cancer are correlated with poorer oncological outcomesMiriam Tomaciello, Antonio Sciurti, Luisa Caprara, et al.
International Journal of Colorectal Disease|January 24, 2026
Anastomotic configurations and early endoscopic recurrence following ileocolonic resection in Crohn's disease: systematic review and meta-analysisAndrea Vignali, Gaetano Gallo, Francesco Selvaggi, et al.
Pageof 108

Showing results (1011-1020 of 1,077) with videos related to

Sort By:
Pageof 108
Biomedical Reports|January 14, 2020
Palliative radiotherapy in advanced cancer patients treated with immune-checkpoint inhibitors: The PRACTICE studyMelissa Bersanelli, Elisabetta Lattanzi, Nunziata D'Abbiero, et al.
The Canadian Journal of Cardiology|February 4, 2018
Long-Term Outcomes of Percutaneous Coronary Intervention for Chronic Total Occlusion in Patients Who Have Undergone Coronary Artery Bypass Grafting vs Those Who Have NotLorenzo Azzalini, Soledad Ojeda, Aris Karatasakis, et al.
Cell Death & Disease|October 30, 2015
A novel miR-371a-5p-mediated pathway, leading to BAG3 upregulation in cardiomyocytes in response to epinephrine, is lost in Takotsubo cardiomyopathyM d'Avenia, R Citro, M De Marco, et al.
Biochemistry|January 27, 2026
Sweet Protein Allosteric Binding and Activation of the Human T1R2/R3 Sweet Receptor: A Simulation Model Validated by in Vitro Receptor Activation AssayPhillip Vo, Daniel E Connors, Brendan P Sharkey, et al.
JAMA Network Open|November 2, 2023
Antitumor Activity and Safety of Dostarlimab Monotherapy in Patients With Mismatch Repair Deficient Solid Tumors: A Nonrandomized Controlled TrialThierry André, Dominique Berton, Giuseppe Curigliano, et al.
Cell Death & Disease|June 1, 2026
Multi-omics analyses identify EZH2 as a central driver in rhabdomyosarcoma radioresistance and highlight Tazemetostat as an effective radiosensitizer in vitro and in vivoMatteo Cassandri, Antonella Porrazzo, Simona Camero, et al.
United European Gastroenterology Journal|December 24, 2022
Effectiveness of first and second-line empirical treatment in Italy: Results of the European registry on Helicobacter pylori managementLuigi Gatta, Olga P Nyssen, Giulia Fiorini, et al.
Anticancer Research|July 7, 2021
Resilience in Radiotherapy Services During the COVID-19 Emergency: Collaboration Between the Regional Radiation Oncology Departments of Lazio, Abruzzo and MoliseMartina DE Angeli, Dimitri Anzellini, Giancarlo Arcangeli, et al.
International Journal of Radiation Biology|March 4, 2025
Significant interruptions in radiotherapy during curative treatment for prostate cancer are correlated with poorer oncological outcomesMiriam Tomaciello, Antonio Sciurti, Luisa Caprara, et al.
International Journal of Colorectal Disease|January 24, 2026
Anastomotic configurations and early endoscopic recurrence following ileocolonic resection in Crohn's disease: systematic review and meta-analysisAndrea Vignali, Gaetano Gallo, Francesco Selvaggi, et al.
Pageof 108